NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/25/2025
Back to search
Official data from USPTO
CIGNA PATHWELL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CIGNA PATHWELL
ST13
US500000097037992Class
35, 36, 44
Filing
97037992
Registration
7706750
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
02/25/2025
Trademark type
Word
Nice classes
35, 36, 44
Filing date
09/21/2021
Registration date
02/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2025
Last transaction
02/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/01/2022
First use in commerce
06/01/2022
Drawing code
4
Owner type
03
Owner location
Willmington, DE, US
Examiner
AREY, BRANDON LEON
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cigna Intellectual Property, Inc.
Representatives
Cigna Intellectual Property, Inc.
Technical classification
Nice Classes
Class 35Class 36Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Cost management for the healthcare benefit and prescription drug benefit plans of others in the field of pharmaceuticals; business servicespharmaceutical cost management services and drug utilization review services for the prescription drug and medical formulary plans of others; consulting services regarding healthcare costs management and retail pharmacy services; Drug utilization review services and drug and medical formulary cost management services; pharmaceutical and medical cost management services and drug utilization review services; in-network provider advisory services and consultancy servicesstrategic business analysis and business advice in the field of medical insurance regarding pharmacy benefit management and medical benefit management; business data analysis regarding health care benefit plan pharmaceutical end-user behavior and health care benefit plan healthcare use behavior; market study and analysis of healthcarehealthcare benefitspharmacy benefits effecting health behavior change and choice at the patient level; providing business intelligence services in the field of pharmacy benefit management; administration of employee benefit plans concerning pharmacy benefit plans; cost management for pharmacy and heath care benefit servicestrackingmonitoringassessing and analyzing information and statistics regarding patient prescription drug use and healthcare habitsproviding a predictive model to determine patients' future prescription drug and healthcare habits to identify potential cost savings
Class 36
Pharmacy benefit management services; pharmacy benefit management consulting services; medical benefit management services concerning insurance; advisory services and consultancy regarding medical insurance healthcare benefitsin-network coverage and pharmacy benefits; provision of information and analysis in the fields of healthcare plan benefits and pharmacy benefits; prescription health care benefit coverage plans servicesproviding insurance underwriting and claims administration of prescription drug plans for qualified beneficiaries; administration of pharmacy benefit plans concerning insurance; pharmacy benefit management services concerning insurancetrackingmonitoringassessing and analyzing information and statistics regarding patient prescription drug use and healthcare habitsproviding a predictive model to determine patients' future prescription drug and healthcare habitsall to identify clinical benefits; prescription drug and healthcare benefit plan servicesproviding information to patients regarding in-network services in the fields of disease management programs and chronic conditions
Class 44
Advisory services and consultancy regarding healthcare; healthcare serviceswellness and disease management programs for patients; health care servicesdisease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance and providing healthcare and medical information regarding health and safety issues regarding chronic conditions; providing medical information and analysis in the fields of healthcare and pharmaceuticals; providing information in the field of healthcare to pharmacy benefit management services clientsconsultants and brokers
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/05/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/05/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/18/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/14/2024
IUAF
USE AMENDMENT FILED
10/03/2024
EISU
TEAS STATEMENT OF USE RECEIVED
10/03/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/29/2024
EX2G
SOU EXTENSION 2 GRANTED
02/28/2024
EXT2
SOU EXTENSION 2 FILED
02/28/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/28/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/03/2023
EX1G
SOU EXTENSION 1 GRANTED
09/29/2023
EXT1
SOU EXTENSION 1 FILED
09/29/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/29/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2023
PUBO
PUBLISHED FOR OPPOSITION
02/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/18/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/15/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/15/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/15/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/05/2022
GNRT
NON-FINAL ACTION E-MAILED
07/05/2022
CNRT
NON-FINAL ACTION WRITTEN
07/05/2022
DOCK
ASSIGNED TO EXAMINER
06/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/24/2021
NWAP
NEW APPLICATION ENTERED
09/24/2021
Continuous trademark protection
Get notified about every new filing that threatens CIGNA PATHWELL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.